WCG Buys E-clinical Software and Translation Provider VeraSci
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
One of the most attractive pure-play, life sciences players changes hands as RWS bolsters position in fast-growing vertical. Price tag in line with 2015 acquisition of CTi.
Your information will never be shared with third parties. No Spam.